![](https://porib.com/wp-content/uploads/2021/06/farmacia_hospitalaria.jpg)
Oyagüez I, Frías C, Seguí MA, Gómez-Barrera M, Casado MA, Gorgas MQ
Eficiencia de tratamientos oncológicos para tumores sólidos en España
Farm Hosp. 2013;37(3):240-59
![](https://porib.com/wp-content/uploads/2021/07/actas_dermo_sifiliograficas.jpg)
Pujol RM, Puig L, Daudén E, Sánchez-Carazo JL,Toribio J, Vanaclocha F,Yébenes M, Sabater E, Casado MA, Caloto MT, Aragón B on behalf of the VACAP Study investigators
Mental-health self-assessment in patients with moderate to severe psoriasis. An observational, multicentre study of 1,164 patients in Spain, The VACAP study
Actas Dermosifiliogr. 2013;104:897-903
![](https://porib.com/wp-content/uploads/2021/07/actas_dermo_sifiliograficas.jpg)
Daudén E, Pujol R, Sánchez-Carazo JL, Toribio J, Vanaclocha F, Puig L, Yébenes M, Sabater E, Casado MA, Caloto MT, Aragón B
Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP Study
Actas Dermosifilogr. 2013;104(9):807-14
![](https://porib.com/wp-content/uploads/2021/07/health_economics_review-2.jpg)
Sanchez-de la Rosa R, Sabater E, Casado MA
Cost analysis of glatiramer acetate vs. Fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Health Econ Rev. 2013;3:13 doi:10.1186/2191-1991-3-13
![](https://porib.com/wp-content/uploads/2021/06/pharma_market.jpg)
Ballina FJ, Gómez-Barrera M, Lozano V, de Andrés F, Aragón B
Modelos interactivos en el análisis de costes e impacto presupuestario. Ejemplo de aplicación para terapias biológicas en artritis reumatoide
Pharma-Market. Número 50, Marzo-Abril 2013
![](https://porib.com/wp-content/uploads/2021/07/the_european_journal_of_hospital_pharmacy___science_and_practice-1.jpg)
Requena T, Martín MT, Desongles T, Castillo I, Lorente L, Yébenes M